title: Coartem (artemether-lumefantrine) in Africa: the beginning of the end?
authors.forename: Ian M
authors.initials: IM
authors.lastname: Hastings
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Ward
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000235:genetics; D000349:Africa; D000818:Animals; D000962:Antimalarials / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077549:Artemether; D037621:Artemisinins / Q000493:pharmacokinetics / Q000627:therapeutic use; D004351:Drug Resistance / Q000235:genetics; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000493:pharmacokinetics / Q000627:therapeutic use; D005449:Fluorenes / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D000078102:Lumefantrine; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D009154:Mutation; D010963:Plasmodium falciparum / Q000187:drug effects / Q000235:genetics; D015800:Protozoan Proteins / Q000235:genetics
chemical_list: D018528:ATP-Binding Cassette Transporters; D000962:Antimalarials; D037621:Artemisinins; D004983:Ethanolamines; D005449:Fluorenes; D015800:Protozoan Proteins; C059987:mdr gene protein, Plasmodium; D000077549:Artemether; D000078102:Lumefantrine